<DOC>
	<DOCNO>NCT00000373</DOCNO>
	<brief_summary>The purpose study find best treatment Tourette 's Syndrome ( TS ) -spectrum obsessive-compulsive disorder ( OCD ) , include symptom TS , e.g. , repeat involuntary body movement ( tic ) . There 2 part study : In Part 1 , patient place 1 2 group base type OCD , determine medical history family member interview . In Part 2 , patient treat fluvoxamine ( FVX ) 8 week . If patient respond FVX alone , either haloperidol inactive placebo add FVX regimen ; patient take drug combination 4 week . Patients monitor throughout trial .</brief_summary>
	<brief_title>Treatment Obsessive-Compulsive Disorder</brief_title>
	<detailed_description>To advance neurobiology treatment obsessive-compulsive disorder ( OCD ) focus Tourette 's Syndrome ( TS ) -spectrum OCD possible homogeneous form OCD , investigate relevance intact 5-hydroxytryptamine ( 5-HT ) function mechanism anti-OC drug action . The validity TS-spectrum OCD distinct subtype assess use detailed clinical , family , drug treatment response profile adult OCD patient . In Study I , patient divide prospectively 2 putative subtypes ( TS-spectrum non-TS-spectrum OCD ) basis clinical history direct , structured interview family member ( approximately 400 interview ) . In Study II , patient enter 8-week single-blind trial potent selective 5-HT reuptake inhibitor fluoxetine ( FX ) . Patients incomplete response FX alone ( approximately 64 patient ) randomize 4-week double-blind trial FX combination dopamine ( DA ) 2 antagonist olanzapine ( OLA ) placebo ( PLA ) .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Fluvoxamine</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<criteria>Inclusion criterion require subject , age 1470 year , least 1year duration current Diagnostic Statistical Manual Mental DisordersIV ( DSMIV ) principal diagnosis OCD . Furthermore , OCD define rating `` moderate '' great global severity item Clinical Global Impressions ( CGI ) scale YaleBrown Obsessive Compulsive Scale ( YBOCS ) score 19 great . Exclusion criterion include primary depression , schizophrenia , psychotic disorder ; active bipolar disorder ; abuse alcohol significant substance within 6 month ; increase risk seizure history neurosurgery , encephalitis , significant head trauma ; significant medical condition , heart , liver , renal disease . Subjects intelligence quotient le 80 determined Kaufman Brief Intelligence Test ( Kaufman Kaufman 1990 ) exclude .</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Adolescence</keyword>
	<keyword>Adult</keyword>
	<keyword>Antipsychotic Agents</keyword>
	<keyword>Dopamine Antagonists</keyword>
	<keyword>Female</keyword>
	<keyword>Fluvoxamine</keyword>
	<keyword>Haloperidol</keyword>
	<keyword>Human</keyword>
	<keyword>Male</keyword>
	<keyword>Middle Age</keyword>
	<keyword>Obsessive-Compulsive Disorder</keyword>
	<keyword>Placebos</keyword>
	<keyword>Serotonin Uptake Inhibitors</keyword>
	<keyword>Tourette Syndrome</keyword>
	<keyword>Tryptophan</keyword>
	<keyword>Drug Combinations</keyword>
	<keyword>Antipsychotic Agents -- *therapeutic use</keyword>
	<keyword>Fluvoxamine -- *therapeutic use</keyword>
	<keyword>Haloperidol -- *therapeutic use</keyword>
	<keyword>Obsessive-Compulsive Disorder -- *drug therapy</keyword>
	<keyword>Obsessive-Compulsive Disorder -- physiopathology</keyword>
	<keyword>Serotonin Uptake Inhibitors -- *therapeutic use</keyword>
</DOC>